No abstract available
MeSH terms
-
Alemtuzumab
-
Anti-Bacterial Agents / therapeutic use
-
Antibodies, Monoclonal / therapeutic use
-
Antibodies, Monoclonal, Humanized
-
Antibodies, Monoclonal, Murine-Derived
-
Antibodies, Neoplasm / therapeutic use
-
Antineoplastic Agents / therapeutic use
-
Antineoplastic Combined Chemotherapy Protocols / therapeutic use
-
Chromosome Aberrations
-
Cyclophosphamide / therapeutic use
-
Doxorubicin / therapeutic use
-
Etoposide / therapeutic use
-
Gene Expression
-
Humans
-
Interleukin-2 / therapeutic use
-
Lymphoma / diagnosis
-
Lymphoma / genetics*
-
Lymphoma / therapy
-
Prednisone / therapeutic use
-
Risk Factors
-
Rituximab
-
Survival
-
Vaccines / therapeutic use
-
Vincristine / therapeutic use
Substances
-
Anti-Bacterial Agents
-
Antibodies, Monoclonal
-
Antibodies, Monoclonal, Humanized
-
Antibodies, Monoclonal, Murine-Derived
-
Antibodies, Neoplasm
-
Antineoplastic Agents
-
Interleukin-2
-
Vaccines
-
Alemtuzumab
-
Rituximab
-
Vincristine
-
Etoposide
-
Doxorubicin
-
Cyclophosphamide
-
Prednisone
Supplementary concepts
-
CHOP protocol
-
EPOCH protocol